| [1] |
ZHANG J, CAO J, LIU Y, et al. Advances in the pathogenesis of steroid-associated osteonecrosis of the femoral head[J]. Biomolecules, 2024, 14(6): 667. doi:10.3390/biom14060667 .
doi: 10.3390/biom14060667
|
| [2] |
ZHANG F, YAN Y, PENG W, et al. PARK7 promotes repair in early steroid-induced osteonecrosis of the femoral head by enhancing resistance to stress-induced apoptosis in bone marrow mesenchymal stem cells via regulation of the Nrf2 signaling pathway[J]. Cell Death Dis, 2021, 12: 940. doi:10.1038/s41419-021-04226-1 .
doi: 10.1038/s41419-021-04226-1
|
| [3] |
KONARSKI W, POBOŻY T, KONARSKA K, et al. Osteonecrosis related to steroid and alcohol use-an update on pathogenesis[J]. Healthcare, 2023, 11(13): 1846. doi:10.3390/healthcare11131846 .
doi: 10.3390/healthcare11131846
|
| [4] |
XIA C, XU H, et al. β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation leading to the development of glucocorticoid-induced osteonecrosis of the femoral head[J]. eLife, 2024, 12: RP92469. doi:10.7554/elife.92469 .
doi: 10.7554/elife.92469
|
| [5] |
李爱强, 赵宁, 张旭升, 等. 骨髓间充质干细胞来源细胞外囊泡治疗股骨头骨坏死的研究进展[J]. 实用医学杂志, 2025, 41(23): 3631-3637. doi:10.3969/j.issn.1006-5725.2025.23.001 .
doi: 10.3969/j.issn.1006-5725.2025.23.001
|
| [6] |
ZHUANG J, WANG J, ZHANG B, et al. The prophylactic effects of naringin on steroid-induced early-stage osteonecrosis in rats: A preliminary study[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(5): 94-104. doi:10.14715/cmb/2023.69.5.16 .
doi: 10.14715/cmb/2023.69.5.16
|
| [7] |
ZHANG S, WANG H, MENG Q, et al. Recent advances in osteonecrosis of the femoral head: A focus on mesenchymal stem cells and adipocytes[J]. J Transl Med, 2025, 23(1): 592. doi:10.1186/s12967-025-06564-6 .
doi: 10.1186/s12967-025-06564-6
|
| [8] |
XU H, FANG L, ZENG Q, et al. Glycyrrhizic acid alters the hyperoxidative stress-induced differentiation commitment of MSCs by activating the Wnt/β-catenin pathway to prevent SONFH[J]. Food Funct, 2023, 14(2): 946-960. doi:10.1039/d2fo02337g .
doi: 10.1039/d2fo02337g
|
| [9] |
ZUO B, WANG Z, LU H, et al. Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head[J]. Open Med, 2025, 20: 20251145. doi:10.1515/med-2025-1145 .
doi: 10.1515/med-2025-1145
|
| [10] |
WANG C, CEN C, SU H, et al. Integrated multi-omics analysis identifies lipid metabolism biomarkers in ONFH and reveals therapeutic potential of retinoic acid[J]. Sci Rep, 2025, 15: 30716. doi:10.1038/s41598-025-13703-y .
doi: 10.1038/s41598-025-13703-y
|
| [11] |
LIU N, ZHENG C, WANG Q, et al. Treatment of non-traumatic avascular necrosis of the femoral head (Review)[J]. Exp Ther Med, 2022, 23(5): 321. doi:10.3892/etm.2022.11250 .
doi: 10.3892/etm.2022.11250
|
| [12] |
SINGH M, SINGH B, SHARMA K, et al. A molecular troika of angiogenesis, coagulopathy and endothelial dysfunction in the pathology of avascular necrosis of femoral head: A comprehensive review[J]. Cells, 2023, 12(18): 2278. doi:10.3390/cells 12182278 .
doi: 10.3390/cells 12182278
|
| [13] |
HUA X, YU L, ZHU H, et al. Research progress of circRNAs in bone-related diseases[J]. Front Oncol, 2025, 15: 1481322. doi:10.3389/fonc.2025.1481322 .
doi: 10.3389/fonc.2025.1481322
|
| [14] |
郭雪峰, 任艳玲, 于睿, 等. 基于 “久病入络” 理论探讨 “从虚而始, 因虚致瘀, 瘀痹骨络” 的激素性股骨头坏死核心病机观[J]. 中华中医药学刊, 2024, 42(6): 191-194. doi:10.13193/j.issn.1673-7717.2024.06.039 .
doi: 10.13193/j.issn.1673-7717.2024.06.039
|
| [15] |
杨阳, 吴健, 娄塞鹤, 等. 活血化瘀合滋补肝肾法对肾虚血瘀证早中期股骨头缺血性坏死患者的临床疗效[J]. 中成药, 2024, 46(3): 830-833. doi:10.3969/j.issn.1001-1528.2024. 03.019 .
doi: 10.3969/j.issn.1001-1528.2024. 03.019
|
| [16] |
田照, 曾平, 刘金富, 等. 韦贵康运用骨坚散联合奇术手法治疗股骨头坏死经验[J]. 中医杂志, 2023, 64(9): 875-878. doi:10.13288/j.11-2166/r.2023.09.003 .
doi: 10.13288/j.11-2166/r.2023.09.003
|
| [17] |
SUN H, ZHANG W, YANG N, et al. Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply[J]. Cell Death Dis, 2021, 12(11): 1035. doi:10.1038/s41419-021-04313-3 .
doi: 10.1038/s41419-021-04313-3
|
| [18] |
陈奇. 中药药理研究方法学[M]. 3版. 北京: 人民卫生出版社, 2011: 1261-1262.
|
| [19] |
雷宁波, 李盼盼, 邢涛, 等. 基于辨证论治理论剖析股骨头坏死的病因病机及其治疗进展[J]. 中医临床研究, 2025, 17(15): 75-81. doi:10.3969/j.issn.1674-7860.2025.15.017 .
doi: 10.3969/j.issn.1674-7860.2025.15.017
|
| [20] |
尚奇, 任辉, 沈耿杨, 等. 基于肾阴阳理论探讨自噬在激素性骨质疏松症中的作用[J]. 中华中医药杂志, 2018, 33(8): 3300-3303.
|
| [21] |
区志坚, 李希文, 邱华耀, 等. 基于OPG/RANKL/RANK信号通路探究 “引血下行法” 调控激素性股骨头坏死骨代谢表达的影响[J]. 实用医学杂志, 2023, 39(23): 3058-3064. doi:10.3969/j.issn.1006-5725.2023.23.006 .
doi: 10.3969/j.issn.1006-5725.2023.23.006
|
| [22] |
XIANG X N, HE H C, HE C Q. Advances in mechanism and management of bone homeostasis in osteonecrosis: A review article from basic to clinical applications[J]. Int J Surg, 2025, 111(1): 1101-1122. doi:10.1097/js9.0000000000002094 .
doi: 10.1097/js9.0000000000002094
|
| [23] |
丁志清, 郭小平, 潘珊珊, 等. 补肾活血法和痰瘀同治法治疗股骨头坏死的研究进展[J]. 中国民族民间医药, 2015, 24(4): 39-40.
|
| [24] |
刘道兵, 王荣田, 陈卫衡. 从“痰瘀同病”论股骨头坏死的中医药治疗[J]. 中医杂志, 2013, 54(19): 1644-1646.
|
| [25] |
YU X, DOU S, LU L, et al. Relationship between lipid metabolism, coagulation and other blood indices and etiology and staging of non-traumatic femoral head necrosis: A multivariate logistic regression-based analysis[J]. J Orthop Surg Res, 2024, 19(1): 251. doi:10.1186/s13018-024-04715-x .
doi: 10.1186/s13018-024-04715-x
|
| [26] |
ZHONG D, XU G Z, WU J Z, et al. Circ-ITCH sponges miR-214 to promote the osteogenic differentiation in osteoporosis via upregulating YAP1[J]. Cell Death Dis, 2021, 12(4): 340. doi:10.1038/s41419-021-03586-y .
doi: 10.1038/s41419-021-03586-y
|
| [27] |
BURKHARDT L M, BUCHER C H, LÖFFLER J, et al. The benefits of adipocyte metabolism in bone health and regeneration[J]. Front Cell Dev Biol, 2023, 11: 1104709. doi:10.3389/fcell. 2023.1104709 .
doi: 10.3389/fcell. 2023.1104709
|
| [28] |
KIM J S, KIM J W, YEE J, et al. Interactive associations between PPARγ and PPARGC1A and bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis[J]. Pharmaceuticals, 2023, 16(7): 1035. doi:10.3390/ph16071035 .
doi: 10.3390/ph16071035
|
| [29] |
LIU Y, HE T, LI Z, et al. TET2 is recruited by CREB to promote Cebpb, Cebpa, and Pparg transcription by facilitating hydroxymethylation during adipocyte differentiation[J]. iScience, 2023, 26(11): 108312. doi:10.1016/j.isci.2023.108312 .
doi: 10.1016/j.isci.2023.108312
|
| [30] |
YAN H, LI Q, LI M, et al. Ajuba functions as a co-activator of C/EBPβ to induce expression of PPARγ and C/EBPα during adipogenesis[J]. Mol Cell Endocrinol, 2022, 539: 111485. doi:10.1016/j.mce.2021.111485 .
doi: 10.1016/j.mce.2021.111485
|
| [31] |
SCHELLER E L, DOUCETTE C R, LEARMAN B S, et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues[J]. Nat Commun, 2015, 6: 7808. doi:10.1038/ncomms8808 .
doi: 10.1038/ncomms8808
|
| [32] |
GILLET C, DALLA VALLE A, GASPARD N, et al. Osteonecrosis of the femoral head: Lipotoxicity exacerbation in MSC and modifications of the bone marrow fluid[J]. Endocrinology, 2017, 158(3): 490-502. doi:10.1210/en.2016-1687 .
doi: 10.1210/en.2016-1687
|
| [33] |
WANG J, ZHEN C, ZHANG G, et al. A 0.2 T–0.4 T static magnetic field improves the bone quality of mice subjected to hindlimb unloading and reloading through the dual regulation of BMSCs via iron metabolism[J]. Int J Mol Sci, 2024, 25(23): 13136. doi:10.3390/ijms252313136 .
doi: 10.3390/ijms252313136
|
| [34] |
GUO L, LI X, TANG Q Q. Transcriptional regulation of adipocyte differentiation: A central role for CCAAT/enhancer-binding protein (C/EBP) β[J]. J Biol Chem, 2015, 290(2): 755-761. doi:10.1074/jbc.R114.619957 .
doi: 10.1074/jbc.R114.619957
|
| [35] |
WALEWSKA A, JANUCIK A, TYNECKA M, et al. Mesenchymal stem cells under epigenetic control–the role of epigenetic machinery in fate decision and functional properties[J]. Cell Death Dis, 2023, 14(11): 720. doi:10.1038/s41419-023-06239-4 .
doi: 10.1038/s41419-023-06239-4
|